Founded in 2012 by scientists seeking to overcome limitations in traditional biological research methods, 10x Genomics (NASDAQ:TXG) develops instruments, consumables, and software that enable ...

This reflects a shift in demand from instruments to consumables, driven by recent product launches. Additionally, 10x Genomics saw notable market penetration in regions like the Americas ...

while consumables revenue grew 10% Get stock picks, daily rankings, and pro-level trading tools in one powerful platform—Memorial Day sale ending soon. 10x Genomics Inc TXG stock is trading ...

Nearly 100 workers at a Tri-Valley-based biosciences company are in their final weeks on the job this month as 10x Genomics ...

This strength in consumables is a positive indicator of the ongoing utilization of 10X Genomics' platforms by researchers and institutions. Conversely, the Xenium instrumentation line has faced ...

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product ...

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock ...

10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.) Recent Updates Revenue was $154.9 million for the first quarter. Excluding $16.8 million related to a patent litigation settlement, revenue was ...